Home Serum Amyloid A Protein (SAA) in Colorectal Carcinoma
Article
Licensed
Unlicensed Requires Authentication

Serum Amyloid A Protein (SAA) in Colorectal Carcinoma

  • Ines Glojnarić , Martin-Tino Časl , Diana Šimić and Josip Lukač
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 39 Issue 2

Abstract

The changes in serum levels of serum amyloid A protein were studied in 67 patients suffering from colorectal carcinoma and compared to three other major acute phase proteins: C-reactive protein, α1-antichymotrypsin and α1-acid glycoprotein. Although the presence of colorectal carcinoma caused an increase in serum levels of all the acute phase reactants studied, serum amyloid A protein showed the most powerful reaction in pre-operative disease stage, with the mean value of 330 mg/l (range 7–2506 mg/l) as compared to the normal values of <1.2 mg/l obtained in 30 healthy adults. The mean serum amyloid A protein concentration increased to 487 mg/l after surgery, declining during the post-operative clinical course until the sixth chemotherapy cycle (from 167mg/l to 64 mg/l), but never returned to the normal range. In the later chemotherapy cycles, mean serum amyloid A protein increased to 163 mg/l, probably as a result of the disease relapse. According to the statistical relations among exact confidence intervals for proportions, serum amyloid A protein showed the best specificity for colorectal carcinoma of all the acute phase proteins studied (83–100%) and also a sensitivity of 100%. We concluded that serum amyloid A protein seems to be a reliable parameter, which could be recommended for clinical routine as a non-specific tumour marker for colorectal carcinoma.

:
Published Online: 2005-06-01
Published in Print: 2001-04-09

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Special Issues of the Journal
  2. Clinical Biological and Genetic Heterogeneity of the Inborn Errors of Pulmonary Surfactant Metabolism
  3. The Effects of Impaired Trace Element Status on Polymorphonuclear Leukocyte Activation in the Development of Vascular Complications in Type 2 Diabetes Mellitus
  4. Free and Complexed Prostate-Specific Antigen (PSA) in the Early Detection of Prostate Cancer
  5. Heterogeneity of DNA Methylation Status Analyzed by Bisulfite-PCR-SSCP and Correlation with Clinico-Pathological Characteristics in Colorectal Cancer
  6. Serum Amyloid A Protein (SAA) in Colorectal Carcinoma
  7. Metal Exposure from Amalgam Alters the Distribution of Trace Elements in Blood Cells and Plasma
  8. Diabetic Cataract and the Total Antioxidant Status in Aqueous Humor
  9. Candidate Gene Polymorphism in Cardiovascular Disease: A Comparative Study of Frequencies between a French and an Italian Population
  10. Reference Values for Plasma Dipeptidyl Peptidase IV Activity and Their Association with Other Laboratory Parameters
  11. Influence of Index of Individuality on False Positives in Repeated Sampling from Healthy Individuals
  12. Regional Reference Values for some Quantities Measured with the ADVIA Centaur Analyser. A Model of Co-operation between the In Vitro Diagnostic Industry and Clinical Laboratories
  13. Tissue Polypeptide-Specific Antigen (TPS) Concentrations in Cerebrospinal Fluid in Patients with Breast Cancer Metastases in the Central Nervous System
  14. The Measurement of Anti-Hepatitis C Virus Antibody in Sera Using a New Generation Immunoassay
  15. Quality Specifications for Cardiac Troponin Assays
  16. IFCC News January 2001
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2001.022/html
Scroll to top button